Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02332993 · ClinicalTrials.gov registry record
Nutritional Regulation of Wound Inflammation: Part III
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 22
- Enrollment target
NCT02332993: Completed study, sponsored by Ohio State University.
NCT02332993 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02332993 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is available over the counter. ImmunAge (FPP) is an investigational drug, which means it has not been approved by the U. S. Food and Drug Administration (FDA). Approximately 30 subjects will participate in this study. 15 subjects will take the supplementation and 15 subjects to take no supplementation as the control. The
Primary Outcome
determine the effect of Oral supplementation of FPP on wound macrophage ROS (reactive oxygen species rod outer segment) production and NADPH oxidase expression (RAC levels) in adult T2DM patients with wounds receiving negative pressure therapy
Interventions
- DIETARY_SUPPLEMENT FPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-02-10 |
What the finished NCT02332993 record still lists
NCT02332993 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FPP is the first listed.
NCT02332993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02332993 about?
NCT02332993 is a clinical study titled "Nutritional Regulation of Wound Inflammation: Part III". The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is avail...
What is the current status of trial NCT02332993?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2014-12. Estimated completion is 2018-02-10.
What interventions are being tested in trial NCT02332993?
The interventions under investigation include: FPP (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02332993?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia